Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
67%(2 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed360%
unknown120%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
completednot_applicable

Intervention to Prevent Peer Violence & Depressive Symptoms Among At-Risk Adolescents

NCT03626103
recruitingnot_applicable

MyChart Proxy Outreach to Parents (MyPOP)

NCT05989308
completednot_applicable

Mailed FIT Outreach 2022

NCT05341622
completednot_applicable

Text My Hypertension BP Meds NOLA

NCT05074173
unknownnot_applicable

Evaluation of an Interactive Risk Information Tool to Increase COVID-19 Vaccination Incidence in Vaccine-hesitant People

NCT05193903

Clinical Trials (5)

Showing 5 of 5 trials
NCT03626103Not Applicable

Intervention to Prevent Peer Violence & Depressive Symptoms Among At-Risk Adolescents

Completed
NCT05989308Not Applicable

MyChart Proxy Outreach to Parents (MyPOP)

Recruiting
NCT05341622Not Applicable

Mailed FIT Outreach 2022

Completed
NCT05074173Not Applicable

Text My Hypertension BP Meds NOLA

Completed
NCT05193903Not Applicable

Evaluation of an Interactive Risk Information Tool to Increase COVID-19 Vaccination Incidence in Vaccine-hesitant People

Unknown

All 5 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
5